Can low-dose combination products for inhalation be formulated in single crystalline particles?

European Journal of Pharmaceutical Sciences

Volumn 40, Issue 1, 2010, Pages 16-24

  Kumon, Michiko ^a   Kwok, Philip Chi Lip ^a   Adi, Handoko ^a   Heng, Desmond ^b   Chan, Hak Kim ^a  

^a University of Sydney   (Australia)

^b INSTITUTE OF CHEMICAL AND ENGINEERING SCIENCES   (Singapore)

Author keywords

Co spray drying; Combination product; Inhaled corticosteroid (ICS); Long acting 2 agonist (LABA); Mannitol

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE PLUS FORMOTEROL; CORTICOSTEROID DERIVATIVE; CRYSTALLIN; FLUTICASONE PROPIONATE PLUS SALMETEROL; LONG ACTING DRUG; MANNITOL; SILICA GEL; ANDROSTANE DERIVATIVE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID; DRUG COMBINATION; ETHANOLAMINE DERIVATIVE; FLUTICASONE, SALMETEROL DRUG COMBINATION; FORMOTEROL; SALBUTAMOL;

AEROSOL; ARTICLE; CONTROLLED STUDY; DISPERSION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG STABILITY; DRUG STORAGE; PARTICLE SIZE; PHYSICAL CHEMISTRY; POWDER; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SPRAY DRYING; ANALOGS AND DERIVATIVES; ATOMIC FORCE MICROSCOPY; CHEMISTRY; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG COMBINATION; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MEDICINAL CHEMISTRY; PROCEDURES; SURFACE PROPERTY; TRANSITION TEMPERATURE; X RAY DIFFRACTION; X RAY PHOTOELECTRON SPECTROSCOPY;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ADRENERGIC BETA-AGONISTS; ALBUTEROL; ANDROSTADIENES; BUDESONIDE; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; CRYSTALLIZATION; DRUG COMBINATIONS; ETHANOLAMINES; HUMANS; MANNITOL; MICROSCOPY, ATOMIC FORCE; MICROSCOPY, ELECTRON, SCANNING; PARTICLE SIZE; PHOTOELECTRON SPECTROSCOPY; SURFACE PROPERTIES; TRANSITION TEMPERATURE; X-RAY DIFFRACTION;

EID: 77951207948     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2010.02.004     Document Type: Article

References (30)

1. Adi H., Young P.M., Chan H.-K., Stewart P., Agus H., Traini D. Cospray dried antibiotics for dry powder lung delivery. Journal of Pharmaceutical Sciences 2008, 97:3356-3366.
2. Adi S., Adi H., Tang P., Traini D., Chan H.-K., Young P.M. Micro-particle corrugation, adhesion and inhalation aerosol efficiency. European Journal of Pharmaceutical Sciences 2008, 35:12-18.
3. British Pharmacopoeia Appendix XII C, 2009. Spottiswoode, London.
4. Burger A., Henck J.-O., Hetz S., Rollinger J.M., Weissnicht A.A., Stöttner H. Energy/temperature diagram and compression behavior of the polymorphs of mannitol. Journal of Pharmaceutical Sciences 2000, 89:457-468.
5. Chan H.-K. What is the role of particle morphology in pharmaceutical powder aerosols?. Expert Opinion on Drug Delivery 2008, 5:909-914.
6. Chan H.-K., Clark A.R., Feeley J.C., Kuo M.-C., Lehrman S.R., Pikal-Cleland K., Miller D.P., Vehring R., Lechuga-Ballesteros D. Physical stability of salmon calcitonin spray-dried powders for inhalation. Journal of Pharmaceutical Sciences 2004, 93:792-804.
7. ®. Journal of Aerosol Medicine 2001, 14:495-501.
8. Clark A.R., Hollingworth A.M. The relationship between powder inhaler resistance and peak inspiratory conditions in healthy volunteers - Implications for in vitro testing. Journal of Aerosol Medicine 1993, 6:99-110.
9. Corrigan D.O., Corrigan O.I., Healy A.M. Physicochemical and in vitro deposition properties of salbutamol sulphate/ipratropium bromide and salbutamol sulphate/excipient spray dried mixtures for use in dry powder inhalers. International Journal of Pharmaceutics 2006, 322:22-30.
10. de Boer A.H., Hagedoorn P., Gjaltema D., Goede J., Kussendrager K.D., Frijlink H.W. Air classifier technology (ACT) in dry powder inhalation Part 2. The effect of lactose carrier surface properties on the drug-to-carrier interaction in adhesive mixtures for inhalation. International Journal of Pharmaceutics 2003, 260:201-216.
11. Glover W., Chan H.-K., Eberl S., Daviskas E., Verschuer J. Effect of particle size of dry powder mannitol on the lung deposition in healthy volunteers. International Journal of Pharmaceutics 2008, 349:314-322.
12. Hannay M., Govind N., Ludzik A., Jansen R., Fletcher I. Overcoming the challenges of developing combination products in different inhalation device platforms. Respiratory Drug Delivery 2008 2008, 319-328. Davis Healthcare International, River Grove, IL. R.N. Dalby, P.R. Byron, J. Peart, J.D. Suman, S.J. Farr, P.M. Young (Eds.).
13. Heng D., Tang P., Cairney J., Chan H.-K., Cutler D., Salama R., Yun J. Focused-ion-beam milling: a novel approach to probing the interior of particles used for inhalation aerosols. Pharmaceutical Research 2007, 24:1608-1617.
14. Hulse W.L., Forbes R.T., Bonner M.C., Getrost M. The characterization and comparison of spray-dried mannitol samples. Drug Development and Industrial Pharmacy 2009, 35:712-718.
15. Islam N., Stewart P., Larson I., Hartley P. Effect of carrier size on the dispersion of salmeterol xinafoate from interactive mixtures. Journal of Pharmaceutical Sciences 2004, 93:1030-1038.
16. Islam N., Stewart P., Larson I., Hartley P. Surface roughness contribution to the adhesion force distribution of salmeterol xinafoate on lactose carriers by atomic force microscopy. Journal of Pharmaceutical Sciences 2005, 94:1500-1511.
17. Kim A.I., Akers M.J., Nail S.L. The physical state of mannitol after freeze-drying: effects of mannitol concentration, freezing rate, and a noncrystallizing cosolute. Journal of Pharmaceutical Sciences 1998, 87:931-935.
18. Larhrib H., Zeng X.M., Martin G.P., Marriott C., Pritchard J. The use of different grades of lactose as a carrier for aerosolised salbutamol sulphate. International Journal of Pharmaceutics 1999, 191:1-14.
19. Learoyd T.P., Burrows J.L., French E., Seville P.C. Sustained delivery by leucine-modified chitosan spray-dried respirable powders. International Journal of Pharmaceutics 2009, 372:97-104.
20. 2-agonists. Current Pharmaceutical Design 2006, 12:3261-3279.
21. Pharmaxis, 2009. Statutory Annual Report. Pharmaxis Ltd., Frenchs Forest, NSW, Australia.
22. Slimane A.B., Mohamed M.C., Vaulay M.-J. Polypyrrole-coated poly(vinyl chloride) powder particles: surface chemical and morphological characterisation by means of X-ray photoelectron spectroscopy and scanning electron microscopy. Colloid and Polymer Science 2004, 282:314-323.
23. Steckel H., Markefka P., teWierik H., Kammelar R. Functionality testing of inhalation grade lactose. European Journal of Pharmaceutics and Biopharmaceutics 2004, 57:495-505.
24. Tajber L., Corrigan O.I., Healy A.M. Spray drying of budesonide, formoterol fumarate and their composites II. Statistical factorial design and in vitro deposition properties. International Journal of Pharmaceutics 2009, 367:86-96.
25. Taki M., Marriott C., Zeng X.-M., Martin G.P. An investigation into the influence of particle size, drug-drug and drug-excipient interactions on the aerodynamic deposition of drugs aerosolized from single and combination dry powder inhalers. Respiratory Drug Delivery 2008 2008, 589-592. Davis Healthcare International, River Grove, IL. R.N. Dalby, P.R. Byron, J. Peart, J.D. Suman, S.J. Farr, P.M. Young (Eds.).
26. Tang P., Chan H.-K., Chiou H., Ogawa K., Jones M.D., Adi H., Buckton G., Prud'homme R.K., Raper J.A. Characterization and aerosolization of mannitol particles produced via confined liquid impinging jets. International Journal of Pharmaceutics 2009, 367:51-57.
27. Traini D., Young P.M., Thielmann F., Acharya M. The influence of lactose pseudopolymorphic form on salbutamol sulfate-lactose interactions in DPI formulations. Drug Development and Industrial Pharmacy 2008, 34:992-1001.
28. Vehring R. Pharmaceutical particle engineering via spray drying. Pharmaceutical Research 2008, 25:999-1022.
29. Westmeier R., Steckel H. Combination particles containing salmeterol xinafoate and fluticasone propionate: formulation and aerodynamic assessment. Journal of Pharmaceutical Sciences 2008, 97:2299-2310.
30. Young P.M., Robert P., Michael J.T., Mark B., Fiona D. Investigation into the effect of humidity on drug-drug interactions using the atomic force microscope. Journal of Pharmaceutical Sciences 2003, 92:815-822.